SPAC Overview
Timeline Progress
- Registration2026-06-08 Filed S1
- IPO2026-07-13 IPO, search begins
- Definitive AgreementNo merger agreement yet
- CompletedNot yet completed
About
Research Alliance Corporation IV is a newly organized blank-check company seeking a business combination, with a stated focus on healthcare and healthcare-related companies, including drug development and commercialization, diagnostics, and healthcare technology and services.
Investment Focus
Healthcare, Biopharmaceuticals
Geographic Focus
United States
The terms and the filing trail behind Research Alliance Corp IV
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Underwriters
Extended Team Information
The team is affiliated with RA Capital Management, a life-sciences-focused investment firm. Its leadership includes healthcare investors and operators with experience across healthcare investing, biopharmaceutical companies, and prior SPACs, including the combination with POINT Biopharma.